VicPlas International Ltd. (569) AI Stock Analysis

• Market Cap: S$48.55M
• Dividend Yield: N/A
• Average Volume (3M): 214.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.53
• Revenue Growth: 13.07%
• EPS Growth: -70.37%
• Country: SG
• Employees: 1,000
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): >-0.01
• Shares Outstanding: 511,537,700
• 10 Day Avg. Volume: 63,840
• 30 Day Avg. Volume: 214,866
• PEG Ratio: -0.28
• Price to Book (P/B): 0.65
• Price to Sales (P/S): 0.39
• P/FCF Ratio: -7.77
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 58 Neutral
• Price Target: S$0.00 ▼(-100.00% Downside)

VicPlas International Ltd. faces significant financial challenges, with profitability and cash flow issues being the most pressing concerns. Despite these challenges, the stock shows positive technical momentum, which could attract short-term traders. However, the negative P/E ratio and lack of dividend yield present valuation concerns. Investors should be cautious and consider the company's ability to improve its financial health before making long-term commitments.

VicPlas International Ltd. Business Overview & Revenue Model

Company Description

VicPlas International Ltd. (569) is a Singapore-based company specializing in the manufacturing and distribution of high-quality plastic products primarily for the healthcare and industrial sectors. The company focuses on the production of medical devices, laboratory equipment, and various plastic components. With a commitment to innovation and quality, VicPlas serves a diverse range of clients, enhancing operational efficiency and improving healthcare delivery through its products.

How the Company Makes Money

VicPlas International Ltd. generates revenue through multiple streams, primarily from the sale of its medical devices and laboratory equipment. The company capitalizes on long-term contracts and partnerships with healthcare institutions and laboratories, providing them with essential plastic products that meet stringent regulatory standards. Additionally, VicPlas benefits from recurring revenue through maintenance and supply agreements, ensuring a steady cash flow. The company's focus on research and development allows it to introduce new products, thereby expanding its market presence and attracting new clients, contributing further to its earnings.

VicPlas International Ltd. Financial Statement Overview

Summary

VicPlas International Ltd. is experiencing financial challenges despite moderate revenue growth. The company has a stable gross profit margin but struggles with profitability, as indicated by a negative net profit margin and low EBIT margin. The balance sheet shows moderate leverage, but the negative return on equity is concerning. Cash flow analysis reveals growth in free cash flow, yet the overall cash position is weak.

Income Statement

VicPlas International Ltd. has shown a moderate revenue growth rate of 4.61% in the latest year, with a gross profit margin of 55.10%. However, the company is facing challenges with profitability, as indicated by a negative net profit margin of -1.95%. The EBIT margin is also low at 0.84%, suggesting operational inefficiencies. Despite these challenges, the company has managed to increase its revenue over the past year.

Balance Sheet

The company's debt-to-equity ratio stands at 0.58, indicating a moderate level of leverage. The return on equity is negative at -3.30%, reflecting the company's struggle to generate profits from shareholders' equity. The equity ratio is not explicitly provided, but the overall balance sheet suggests a stable asset base with moderate leverage.

Cash Flow

VicPlas International Ltd. has experienced a positive free cash flow growth rate of 19.64%, but the free cash flow remains negative. The operating cash flow to net income ratio is low at 0.78%, indicating that the company's cash generation from operations is insufficient to cover its net losses. The free cash flow to net income ratio is significantly negative, highlighting cash flow challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	120.81M	120.81M	102.39M	129.22M	130.81M	113.94M
Gross Profit	66.57M	66.57M	52.42M	66.19M	68.06M	60.84M
EBITDA	7.01M	7.01M	6.93M	13.18M	17.93M	19.03M
Net Income	-2.36M	-2.36M	-1.36M	4.24M	8.84M	10.40M
Balance Sheet
Total Assets	137.71M	137.71M	131.49M	119.02M	130.34M	111.66M
Cash, Cash Equivalents and Short-Term Investments	4.71M	4.71M	4.97M	8.57M	8.89M	9.87M
Total Debt	41.11M	41.11M	32.47M	17.55M	28.01M	19.57M
Total Liabilities	66.32M	66.32M	56.93M	40.46M	52.03M	40.01M
Stockholders Equity	71.39M	71.39M	74.57M	78.56M	78.31M	71.64M
Cash Flow
Free Cash Flow	-5.99M	-5.99M	-7.82M	12.53M	-2.61M	3.83M
Operating Cash Flow	388.00K	388.00K	6.72M	17.88M	10.25M	9.01M
Investing Cash Flow	-9.53M	-6.36M	-14.53M	-5.10M	-12.79M	-5.16M
Financing Cash Flow	8.63M	5.75M	4.24M	-12.76M	1.63M	1.86M

VicPlas International Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:569, the sentiment is Positive. The current price of 0.1 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.09, and above the 200-day MA of 0.08, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 66.66 is Neutral, neither overbought nor oversold. The STOCH value of 133.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:569.

VicPlas International Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1B1	―	S$52.29M	6.19	47.36%	―	1.58%	115.29%
569	―	S$48.55M	―	-3.23%	―	13.07%	-70.37%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
8YY	―	S$39.87M	―	―	―	―	―